IJMS | Free Full-Text | Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies | HTML
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease - ScienceDirect
Full-length tau showing the discussed tau antibodies, their respective... | Download Scientific Diagram
Tau Clinical Trials – What can be learned from failure? - Etap Lab
AC Immune Reports Top Line Results from TAURIEL Phase 2
Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease - Journal of Pharmaceutical Sciences
PRECLINICAL AND CLINICAL DEVELOPMENT OF ABBV-8E12, A HUMANIZED ANTI-TAU ANTIBODY, FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES • The Journal of Prevention of Alzheimer's Disease
FIRST SUBJECT ENROLLED IN PHASE II/III STUDY OF EISAI'S ANTI-MTBR TAU ANTIBODY E2814 FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE (DIAD), CONDUCTED BY DIAN-TU
Semorinemab Slows Cognition Decline in Alzheimer's, Trial Results Show
Vaccination strategies in tauopathies and synucleinopathies - Braczynski - 2017 - Journal of Neurochemistry - Wiley Online Library
More Tau Antibodies Bid Adieu; Semorinemab Keeps Foot in Door | ALZFORUM
Tau-targeting therapies for Alzheimer disease. - Abstract - Europe PMC
N-Terminal Tau Antibodies Fade, Mid-Domain Ones Push to the Fore | ALZFORUM
Anti-Tau Antibodies: Hitting the Target - ScienceDirect
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice | Alzheimer's Research & Therapy | Full Text
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies | npj Vaccines
Therapeutic antibodies targeting Tau or TREM2 in clinical trials for... | Download Scientific Diagram
Current Status of Clinical Trials on Tau Immunotherapies | SpringerLink
N-Terminal Tau Antibodies Fade, Mid-Domain Ones Push to the Fore | ALZFORUM
Tau-targeting therapies for Alzheimer disease. - Abstract - Europe PMC
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement - ScienceDirect
Frontiers | Targeting Tau to Treat Clinical Features of Huntington's Disease | Neurology
